D.E. Shaw & Co
ELOS

D.E. Shaw & Co’s Syneron Medical Ltd ELOS Stock Holding History

D.E. Shaw & Co’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-126,571
Closed -$1.39M – 3754
2017
Q2 		$1.39M Sell
126,571
-48,303
-28% -$530K ﹤0.01% 2209
2017
Q1 		$1.84M Sell
174,874
-105,631
-38% -$1.02M ﹤0.01% 1900
2016
Q4 		$2.36M Buy
280,505
+14,382
+5% +$113K ﹤0.01% 1873
2016
Q3 		$1.91M Buy
266,123
+59,408
+29% +$413K ﹤0.01% 1970
2016
Q2 		$1.59M Buy
206,715
+31,257
+18% +$223K ﹤0.01% 2100
2016
Q1 		$1.28M Sell
175,458
-14,523
-8% -$104K ﹤0.01% 2185
2015
Q4 		$1.47M Sell
189,981
-77,671
-29% -$592K ﹤0.01% 2365
2015
Q3 		$1.91M Buy
267,652
+66,106
+33% +$635K ﹤0.01% 2129
2015
Q2 		$2.14M Buy
201,546
+41,759
+26% +$489K ﹤0.01% 2155
2015
Q1 		$1.98M Buy
159,787
+66,241
+71% +$733K ﹤0.01% 2022
2014
Q4 		$873K Buy
93,546
+30,097
+47% +$290K ﹤0.01% 2927
2014
Q3 		$636K Sell
63,449
-3,145
-5% -$32K ﹤0.01% 3156
2014
Q2 		$687K Sell
66,594
-1,678
-2% -$18.1K ﹤0.01% 3260
2014
Q1 		$850K Buy
68,272
+30,961
+83% +$367K ﹤0.01% 3176
2013
Q4 		$459K Buy
+37,311
New +$388K ﹤0.01% 3775

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AIM
Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

D.E. Shaw & Co's ELOS Position: Q3 2017 in Review

D.E. Shaw & Co sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 126,571 shares — an estimated $1.39M sold.

D.E. Shaw & Co first reported a position in ELOS in Q4 2013 and held it in 15 quarters. The position peaked at $2.36M in Q4 2016. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

  • D.E. Shaw & Co reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
  • D.E. Shaw & Co sold 126,571 Syneron Medical Ltd shares in Q3 2017, an estimated $1.39M.
  • D.E. Shaw & Co first reported a position in Syneron Medical Ltd in Q4 2013 and held it in 15 quarters.
  • D.E. Shaw & Co's Syneron Medical Ltd position peaked at $2.36M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.